Texas officers heroically rescue unresponsive baby from overturned car, highlighting the critical role of first responders.
Novartis to acquire Avidity Biosciences for $12 billion, bolstering its neuroscience pipeline with late-stage programs.
Analysts warn investors to look beyond short-term momentum and focus on improving unit trends, healthy margins, and sustainable cash generation when evaluating U.S. stocks.
Texas officers heroically rescue unresponsive baby from overturned car, highlighting the critical role of first responders.
Novartis to acquire Avidity Biosciences for $12 billion, bolstering its neuroscience pipeline with late-stage programs.
Analysts warn investors to look beyond short-term momentum and focus on improving unit trends, healthy margins, and sustainable cash generation when evaluating U.S. stocks.
